Imanishi Yuri MD - Roslindale, Massachusetts 02131

Imanishi Yuri MD is categorized under Doctors in Roslindale, MA .

Business Name: Imanishi Yuri MD
Contact Person: Yuri Imanishi
Address: 1200 Center St, Roslindale, Massachusetts 02131
Phone Number: (617) 325-8000
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Emmanuel Woghiren - Roslindale, MA 02131
Moody Betsy L MD - Roslindale, MA 02131
Lipsitz Lewis A MD - Roslindale, MA 02131
Bean Jonathan MD - Roslindale, MA 02131
Fabiny Anne R MD - Roslindale, MA 02131
Kass Robert L MD - Roslindale, MA 02131
Kiel Douglas MD - Roslindale, MA 02131
Mitchell Susan L MD - Roslindale, MA 02131
Protiva Janet S MD - Roslindale, MA 02131
Mendes Antonio C MD - Roslindale, MA 02131
Reddy Madhuri MD - Roslindale, MA 02131
Rhodes-Kropf Jennifer MD - Roslindale, MA 02131
Kamin Ifat MD - Roslindale, MA 02131
Kandel Ruth MD - Roslindale, MA 02131
Ahn Paul B MD - Roslindale, MA 02131
Parikh Seema MD - Roslindale, MA 02131
Nobel Kenneth W MD - Roslindale, MA 02131
Godfrey Chase MD - Roslindale, MA 02131
Inouye Sharon K MD - Roslindale, MA 02131
Fonseka Janaki MD - Roslindale, MA 02131

The company Imanishi Yuri MD provides B2C services in the form of Doctors from its single location in Massachusetts. 1 to 4 employees work for Imanishi Yuri MD, and the business now earns $500.000 to $999.999 per annum.

Imanishi Yuri MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Imanishi Yuri MD, please call Yuri Imanishi with the phone number (617) 325-8000 or visit its single location at 1200 Center St in Roslindale, Massachusetts 02131.

The location of the single location can also be found using the coordinates 42.297165,-71.131833. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.